{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:35:32Z","timestamp":1791084932474,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.2119\/molmed.2016.00222","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T09:32:40Z","timestamp":1494667960000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cathepsin L Promotes Vascular Intimal Hyperplasia after Arterial Injury"],"prefix":"10.1186","volume":"23","author":[{"given":"Jingjing","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinze","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Al-Abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo F.","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Billiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex F.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"key":"2301092_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/01.CIR.79.6.1374","volume":"79","author":"MW Liu","year":"1989","unstructured":"Liu MW, Roubin GS, King SB 3rd. (1989) Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia. Circulation. 79:1374\u201387.","journal-title":"Circulation"},{"key":"2301092_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJM198602203140806","volume":"314","author":"R Ross","year":"1986","unstructured":"Ross R. (1986) The pathogenesis of atherosclerosis: an update. N. Engl. J. Med. 314:488\u2013500.","journal-title":"N. Engl. J. Med."},{"key":"2301092_CR3","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1161\/01.ATV.0000037100.44766.5B","volume":"22","author":"FG Welt","year":"2002","unstructured":"Welt FG, Rogers C. (2002) Inflammation and restenosis in the stent era. Arterioscler. Thromb. Vasc. Biol. 22:1769\u201376.","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2301092_CR4","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1161\/01.CIR.88.4.1788","volume":"88","author":"H Tanaka","year":"1993","unstructured":"Tanaka H, et al. (1993) Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation. 88:1788\u2013803.","journal-title":"Circulation"},{"key":"2301092_CR5","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1161\/01.ATV.0000134530.27208.41","volume":"24","author":"J Liu","year":"2004","unstructured":"Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. (2004) Lysosomal cysteine proteases in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24:1359\u201366.","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2301092_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cellimm.2010.11.004","volume":"267","author":"BM Creasy","year":"2011","unstructured":"Creasy BM, McCoy KL. (2011) Cytokines regulate cysteine cathepsins during TLR responses. Cell Immunol. 267:56\u201366.","journal-title":"Cell Immunol."},{"key":"2301092_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/cvr\/cvq328","volume":"89","author":"M Sun","year":"2011","unstructured":"Sun M, et al. (2011) Cathepsin-L contributes to cardiac repair and remodelling post-infarction. Cardiovasc. Res. 89:374\u201383.","journal-title":"Cardiovasc. Res."},{"key":"2301092_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nm1182","volume":"11","author":"C Urbich","year":"2005","unstructured":"Urbich C, et al. (2005) Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat. Med. 11:206\u201313.","journal-title":"Nat. Med."},{"key":"2301092_CR9","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1161\/ATVBAHA.111.230201","volume":"31","author":"J Sun","year":"2011","unstructured":"Sun J, et al. (2011) Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler. Thromb. Vasc. Biol. 31:2500\u201308.","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2301092_CR10","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1021\/bi982175f","volume":"38","author":"D Bromme","year":"1999","unstructured":"Bromme D, Li Z, Barnes M, Mehler E. (1999) Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry. 38:2377\u201385.","journal-title":"Biochemistry"},{"key":"2301092_CR11","first-page":"1624","volume":"58","author":"I Santamaria","year":"1998","unstructured":"Santamaria I, et al. (1998) Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. Cancer Res. 58:1624\u201330.","journal-title":"Cancer Res."},{"key":"2301092_CR12","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1161\/ATVBAHA.115.305789","volume":"35","author":"J Cai","year":"2015","unstructured":"Cai J, et al. (2015) HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4. Arterioscler. Thromb. Vasc. Biol. 35:2579\u201393.","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2301092_CR13","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1161\/01.CIR.0000018168.15904.BB","volume":"105","author":"HD Danenberg","year":"2002","unstructured":"Danenberg HD, et al. (2002) Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation. 105:2917\u201322.","journal-title":"Circulation"},{"key":"2301092_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1161\/01.CIR.101.8.908","volume":"101","author":"LJ Feldman","year":"2000","unstructured":"Feldman LJ, et al. (2000) Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation. 101:908\u201316.","journal-title":"Circulation"},{"key":"2301092_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/cvr\/cvr075","volume":"91","author":"A Saxena","year":"2011","unstructured":"Saxena A, et al. (2011) The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling. Cardiovasc. Res. 91:350\u201357.","journal-title":"Cardiovasc. Res."},{"key":"2301092_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/cvr\/cvr238","volume":"92","author":"LL Zhang","year":"2011","unstructured":"Zhang LL, et al. (2011) PPARgamma attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Cardiovasc. Res. 92:484\u201393.","journal-title":"Cardiovasc. Res."},{"key":"2301092_CR17","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1084\/jem.20081298","volume":"205","author":"PC Tang","year":"2008","unstructured":"Tang PC, et al. (2008) MyD88-dependent, superoxide-initiated inflammation is necessary for flow-mediated inward remodeling of conduit arteries. J. Exp. Med. 205:3159\u201371.","journal-title":"J. Exp. Med."},{"key":"2301092_CR18","doi-asserted-by":"publisher","first-page":"G531","DOI":"10.1152\/ajpgi.00060.2010","volume":"299","author":"BM Buchholz","year":"2010","unstructured":"Buchholz BM, Billiar TR, Bauer AJ. (2010) Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus. Am. J. Physiol. Gastrointest. Liver Physiol. 299:G531\u201338.","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2301092_CR19","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1161\/01.ATV.17.10.2238","volume":"17","author":"A Kumar","year":"1997","unstructured":"Kumar A, Lindner V. (1997) Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler. Thromb. Vasc. Biol. 17:2238\u201344.","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2301092_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jvs.2010.03.048","volume":"52","author":"P Yu","year":"2010","unstructured":"Yu P, Nguyen BT, Tao M, Campagna C, Ozaki CK. (2010) Rationale and practical techniques for mouse models of early vein graft adaptations. J. Vasc. Surg. 52:444\u201352.","journal-title":"J. Vasc. Surg."},{"issue":"3","key":"2301092_CR21","first-page":"538","volume":"5","author":"JP Pribis","year":"2015","unstructured":"Pribis JP, et al. (2015) The HIV protease inhibitor saquinavir inhibits HMGB1 driven inflammation by targeting the interaction of cathepsin V with TLR4\/MyD88. Mol. Med. 5(3):538\u201346.","journal-title":"Mol. Med."},{"key":"2301092_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev.physiol.59.1.63","volume":"59","author":"HA Chapman","year":"1997","unstructured":"Chapman HA, Riese RJ, Shi GP. (1997) Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59:63\u201388.","journal-title":"Annu. Rev. Physiol."},{"key":"2301092_CR23","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/HYPERTENSIONAHA.111.180935","volume":"58","author":"XW Cheng","year":"2011","unstructured":"Cheng XW, Huang Z, Kuzuya M, Okumura K, Murohara T. (2011) Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. Hypertension. 58:978\u201386.","journal-title":"Hypertension"},{"key":"2301092_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.pharmthera.2011.04.010","volume":"131","author":"Y Qin","year":"2011","unstructured":"Qin Y, Shi GP. (2011) Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases. Pharmacol. Ther. 131:338\u201350.","journal-title":"Pharmacol. Ther."},{"key":"2301092_CR25","doi-asserted-by":"publisher","first-page":"34871","DOI":"10.1074\/jbc.M113.510008","volume":"288","author":"X Du","year":"2013","unstructured":"Du X, Chen NL, Wong A, Craik CS, Bromme D. (2013) Elastin degradation by cathepsin V requires two exosites. J. Biol. CChem. 288:34871\u201381.","journal-title":"J. Biol. CChem."},{"key":"2301092_CR26","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1161\/STROKEAHA.111.627265","volume":"42","author":"I Cicha","year":"2011","unstructured":"Cicha I, et al. (2011) Carotid plaque vulnerability: a positive feedback between hemodynamic and biochemical mechanisms. Stroke. 42:3502\u201310.","journal-title":"Stroke"},{"key":"2301092_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2008.03.027","volume":"202","author":"W Li","year":"2009","unstructured":"Li W, Kornmark L, Jonasson L, Forssell C, Yuan XM. (2009) Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Atherosclerosis. 202:92\u2013102.","journal-title":"Atherosclerosis"},{"issue":"17","key":"2301092_CR28","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1089\/ars.2015.6408","volume":"23","author":"J Cai","year":"2015","unstructured":"Cai J, Wen J, Bauer E, Zhong H, Yuan H, Chen A (2015) The Role of HMGB1 in Cardiovascular Biology: Danger Signals. Antioxid. Redox, Signal. 23(17):1351\u201369.","journal-title":"Antioxid. Redox, Signal."},{"key":"2301092_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira S, Takeda K, Kaisho T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675\u201380.","journal-title":"Nat. Immunol."},{"key":"2301092_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1385\/IR:34:3:193","volume":"34","author":"AE Mullick","year":"2006","unstructured":"Mullick AE, Tobias PS, Curtiss LK. (2006) Toll-like receptors and atherosclerosis: key contributors in disease and health? Immunol. Res. 34:193\u2013209.","journal-title":"Immunol. Res."},{"key":"2301092_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4067\/S0716-97602007000200001","volume":"40","author":"SA Arancibia","year":"2007","unstructured":"Arancibia SA, et al. (2007) Toll-like receptors are key participants in innate immune responses. Biol. Res. 40:97\u2013112.","journal-title":"Biol. Res."},{"key":"2301092_CR32","doi-asserted-by":"publisher","first-page":"8256","DOI":"10.1158\/0008-5472.CAN-05-1220","volume":"65","author":"AK Gupta","year":"2005","unstructured":"Gupta AK, Cerniglia GJ, Mick R, McKenna WG, Muschel RJ. (2005) HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo. Cancer Res. 65:8256\u201365.","journal-title":"Cancer Res."},{"key":"2301092_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1470-2045(03)01192-6","volume":"4","author":"C Sgadari","year":"2003","unstructured":"Sgadari C, Monini P, Barillari G, Ensoli B. (2003) Use of HIV protease inhibitors to block Kaposi\u2019s sarcoma and tumour growth. Lancet Oncol. 4:537\u201347.","journal-title":"Lancet Oncol."},{"key":"2301092_CR34","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1161\/CIRCULATIONAHA.110.973750","volume":"122","author":"G Gary-Bobo","year":"2010","unstructured":"Gary-Bobo G, et al. (2010) Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats. Circulation. 122:1937\u201347.","journal-title":"Circulation"},{"key":"2301092_CR35","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1093\/ndt\/gfs035","volume":"27","author":"R Coppo","year":"2012","unstructured":"Coppo R, et al. (2012) Saquinavir in steroid-dependent and -resistant nephrotic syndrome: a pilot study. Nephrol. Dial. Transplant. 27:1902\u201310.","journal-title":"Nephrol. Dial. Transplant."},{"key":"2301092_CR36","first-page":"17","volume":"8","author":"T Wolf","year":"2003","unstructured":"Wolf T, Findhammer S, Nolte B, Helm EB, Brodt HR. (2003) Inhibition of TNF-alpha mediated cell death by HIV-1 specific protease inhibitors. Eur. J. Med. Res. 8:17\u201324.","journal-title":"Eur. J. Med. Res."},{"key":"2301092_CR37","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1128\/AAC.48.10.3905-3911.2004","volume":"48","author":"O Equils","year":"2004","unstructured":"Equils O, Shapiro A, Madak Z, Liu C, Lu D. (2004) Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-induced NF-kappaB activation. Antimicrob. Agents Chemother. 48:3905\u201311.","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2016.00222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2016.00222\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.molmed.org\/content\/pdfstore\/16_222_Cai.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2016.00222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T05:40:12Z","timestamp":1554529212000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2016.00222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["2301092"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2016.00222","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"12 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}